Dr. Joshua C. Nwabuife | Targeted Therapy | Best Researcher Award
Postdoctoral Research Fellow at University of The Free State | South Africa
Dr. Joshua C. Nwabuife is a dedicated researcher and academic in the field of pharmaceutics and nanomedicine. His expertise lies in the development of innovative drug delivery systems, nanotechnology-based therapeutics, and advanced pharmaceutical formulations. He has contributed to research on cancer therapy, antimicrobial agents, and strategies to enhance the bioavailability of poorly soluble drugs. Passionate about translational research, Dr. Nwabuife works to bridge laboratory discoveries with real-world clinical applications, aiming to advance patient-centered healthcare solutions and next-generation pharmaceutical technologies.
Professional Profile
Scopus Profile
Orcid Profile
Education
Dr. Joshua C. Nwabuife pursued his academic journey in pharmaceutical sciences, beginning with his undergraduate studies in Pharmacy, where he built a strong foundation in pharmacology, pharmaceutics, and drug development. He went on to earn a Master’s degree in Pharmaceutics, focusing on advanced drug delivery systems and the formulation of novel therapeutic agents. Building on this expertise, he obtained his Ph.D. in Pharmaceutics, with research centered on nano-based drug delivery systems for cancer therapeutics and antimicrobial resistance. His doctoral work emphasized the design, characterization, and application of nanotechnology-driven approaches for improved treatment outcomes, positioning him at the forefront of pharmaceutical innovation.
Experience
Dr. Joshua C. Nwabuife has built extensive experience in the field of pharmaceutical sciences, with a strong focus on pharmaceutics, nanomedicine, and drug delivery systems. He has served in both academic and research roles, contributing to teaching, mentoring, and advancing knowledge in pharmaceutical formulation and therapeutics. His expertise lies in developing nano-based drug delivery platforms for cancer treatment, antimicrobial therapy, and improved bioavailability of poorly soluble drugs. In addition to his research work, he has participated in collaborative projects, presented findings at scientific conferences, and published in reputable journals. Through his academic contributions, innovative research, and commitment to training the next generation of pharmaceutical scientists, Dr. Nwabuife has established himself as a dedicated researcher and educator in the pharmaceutical sciences community.
Research Interests
Dr. Joshua C. Nwabuife’s research interests center on pharmaceutics, nanomedicine, and advanced drug delivery systems. He focuses on the design and development of nanoformulations for cancer therapy, antimicrobial treatments, and targeted drug delivery to improve therapeutic efficiency and reduce side effects. His work explores strategies to enhance the solubility and bioavailability of poorly water-soluble drugs, employing nanotechnology-based approaches such as nanoparticles, liposomes, and polymeric carriers. Additionally, he is interested in translational research aimed at bridging laboratory innovations with clinical applications, particularly in oncology, infectious diseases, and chronic illness management. Through this, Dr. Nwabuife seeks to contribute to the advancement of patient-centered therapies and the development of next-generation pharmaceuticals.
Publications
Release Monitoring and Detection of Formulated Solid Nanoparticle–Conjugated Nicotine in Blood and Urine Using Electrochemical Technique
Revolutionizing drug delivery: The promise of surface functionalized dendrimers in overcoming conventional limitations
Novel folic acid-functionalized smart Eicosapentaenoic acid liposomes for the targeted delivery of quercetin against cancer
A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19
Hyaluronidase inhibitor surface-modified niosomes: An efficient strategy for antibacterial and anti-biofilm drug delivery
Conclusion
Dr. Joshua C. Nwabuife exemplifies excellence in scientific research, innovation, and academic leadership. His work in nano drug delivery, antimicrobial resistance, and cancer therapeutics demonstrates originality, rigor, and translational potential. With a strong foundation of skills, publications, and international recognition, coupled with his dedication to mentoring future scientists, he is highly suitable for the Best Researcher Award.